Business Wire

Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...
Nasdaq

Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...
Healio

Phaco-DMEK with Vivity IOL implantation shows good outcomes in Fuchs’ dystrophy patients

Please provide your email address to receive an email when new articles are posted on . Combined phaco-DMEK leads to equally good vision as phaco and DMEK performed separately. The decrease in ...
Morningstar

Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025

†Compared to CENTURION and CONSTELLATION Vision Systems. Based on bench data. **Based on worldwide unit sales of AcrySof® IQ Vivity and Clareon Vivity IOLs, as of Q4, 2024. “As ophthalmic practices ...
Seeking Alpha

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity ®, the most widely implanted 9 extended ...